- Home
- STG vs SGMO Comparison
STG vs SGMO Comparison
Compare STG & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- SGMO
- Stock Information
- Founded
- STG 2003
- SGMO 1995
- Country
- STG China
- SGMO United States
- Employees
- STG N/A
- SGMO N/A
- Industry
- STG Other Consumer Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STG Real Estate
- SGMO Health Care
- Exchange
- STG Nasdaq
- SGMO Nasdaq
- Market Cap
- STG 108.2M
- SGMO 180.5M
- IPO Year
- STG 2018
- SGMO 2000
- Fundamental
- Price
- STG $7.42
- SGMO $0.94
- Analyst Decision
- STG
- SGMO Buy
- Analyst Count
- STG 0
- SGMO 4
- Target Price
- STG N/A
- SGMO $2.67
- AVG Volume (30 Days)
- STG 29.2K
- SGMO 2.5M
- Earning Date
- STG 11-20-2024
- SGMO 10-30-2024
- Dividend Yield
- STG N/A
- SGMO N/A
- EPS Growth
- STG N/A
- SGMO N/A
- EPS
- STG 4.83
- SGMO N/A
- Revenue
- STG $286,479,516.00
- SGMO $12,277,000.00
- Revenue This Year
- STG N/A
- SGMO N/A
- Revenue Next Year
- STG N/A
- SGMO $52.02
- P/E Ratio
- STG $1.51
- SGMO N/A
- Revenue Growth
- STG N/A
- SGMO N/A
- 52 Week Low
- STG $4.25
- SGMO $0.29
- 52 Week High
- STG $12.55
- SGMO $1.48
- Technical
- Relative Strength Index (RSI)
- STG 50.02
- SGMO 58.17
- Support Level
- STG $7.02
- SGMO $0.77
- Resistance Level
- STG $8.56
- SGMO $1.07
- Average True Range (ATR)
- STG 0.75
- SGMO 0.07
- MACD
- STG -0.01
- SGMO 0.01
- Stochastic Oscillator
- STG 24.45
- SGMO 59.30
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.